Immune-checkpoint-inhibitor therapy directed against PD-L1 is tolerated in the heart without manifestation of cardiac inflammation in a preclinical reversible melanoma mouse model - Schoenherr, Caroline; Pietzsch, Stefan; Barca, Cristina; Müller, Franziska E.; Bahr, Frauke S.; Kasten, Martina; Zeug, Andre; Erschow, Sergej; Falk, Christine S.; Ponimaskin, Evgeni; Thackeray, James T.; Hilfiker-Kleiner, Denise; et al. (Frontiers in Molecular Medicine, 2025)